103907-09-1Relevant articles and documents
Design and synthesis of piperidine farnesyltransferase inhibitors with reduced glucuronidation potential
Tanaka, Rieko,Rubio, Almudena,Harn, Nancy K.,Gernert, Douglas,Grese, Timothy A.,Eishima, Jun,Hara, Mitsunobu,Yoda, Nobuyuki,Ohashi, Rui,Kuwabara, Takashi,Soga, Shiro,Akinaga, Shiro,Nara, Shinji,Kanda, Yutaka
, p. 1363 - 1382 (2007)
The design and synthesis of a novel piperidine series of farnesyltransferase (FTase) inhibitors with reduced potential for metabolic glucuronidation are described. The various substitution and exchange of the phenyl group at the C-2 position of the previously described 2-(4-hydroxy)phenyl-3-nitropiperidine 1a (FTase IC50 = 5.4 nM) resulted in metabolically stable compounds with potent FTase inhibition (14a IC50 = 4.3 nM, 20a IC50 = 3.0 nM, and 50a IC50 = 16 nM). Molecular modeling studies of these compounds complexed with FTase and farnesyl pyrophosphate are also described.